Hemogenyx Pharmaceuticals Plc (LON:HEMO)

Hemogenyx Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	40	14	27	13	18	42
Market Cap Growth	185.24%	-47.51%	108.28%	-29.33%	-56.10%	494.04%
Enterprise Value	42	15	27	7	9	40
Last Close Price	6.68	4.05	9.20	5.30	7.50	38.60
PB Ratio	-73.86	16.63	9.72	4.00	2.25	47.79
P/TBV Ratio	-	33.78	11.51	4.58	2.37	65.81
Debt / Equity Ratio	-4.03	3.07	1.06	1.06	0.00	1.86
Quick Ratio	0.43	0.14	1.69	3.40	19.41	1.05
Current Ratio	0.43	0.72	2.93	3.47	20.23	1.08
Return on Equity (ROE)	-631.11%	-309.56%	-222.31%	-69.88%	-112.98%	-795.61%
Return on Assets (ROA)	-70.68%	-65.14%	-61.24%	-44.28%	-30.20%	-72.36%
Return on Capital Employed (ROCE)	-293.10%	-176.10%	-120.50%	-87.20%	-33.10%	-242.80%
Earnings Yield	-19.35%	-39.59%	-24.75%	-30.65%	-27.76%	-4.98%
FCF Yield	-13.85%	-29.26%	-23.02%	-25.72%	-17.77%	-4.71%
Buyback Yield / Dilution	-15.82%	-16.95%	-15.25%	-26.59%	-86.57%	-15.00%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.